ES452060A1 - Procedimiento para preparar compuestos antihistaminicos. - Google Patents

Procedimiento para preparar compuestos antihistaminicos.

Info

Publication number
ES452060A1
ES452060A1 ES452060A ES452060A ES452060A1 ES 452060 A1 ES452060 A1 ES 452060A1 ES 452060 A ES452060 A ES 452060A ES 452060 A ES452060 A ES 452060A ES 452060 A1 ES452060 A1 ES 452060A1
Authority
ES
Spain
Prior art keywords
ring
lower alkyl
bromine
sulfur
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES452060A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline & French Laboratories Ltd
Original Assignee
Smith Kline & French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline & French Laboratories Ltd filed Critical Smith Kline & French Laboratories Ltd
Publication of ES452060A1 publication Critical patent/ES452060A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES452060A 1975-10-02 1976-10-01 Procedimiento para preparar compuestos antihistaminicos. Expired ES452060A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4034175 1975-10-02

Publications (1)

Publication Number Publication Date
ES452060A1 true ES452060A1 (es) 1977-10-01

Family

ID=10414412

Family Applications (1)

Application Number Title Priority Date Filing Date
ES452060A Expired ES452060A1 (es) 1975-10-02 1976-10-01 Procedimiento para preparar compuestos antihistaminicos.

Country Status (36)

Country Link
JP (2) JPS5246087A (enExample)
AR (1) AR221682A1 (enExample)
AT (1) AT358045B (enExample)
AU (1) AU504897B2 (enExample)
BE (1) BE846452A (enExample)
BG (1) BG25224A3 (enExample)
CA (1) CA1067076A (enExample)
CH (1) CH625801A5 (enExample)
CS (1) CS203003B2 (enExample)
DD (1) DD126563A5 (enExample)
DE (1) DE2643670C2 (enExample)
DK (1) DK442476A (enExample)
ES (1) ES452060A1 (enExample)
FI (1) FI61701C (enExample)
FR (1) FR2326192A1 (enExample)
GR (1) GR61307B (enExample)
HU (1) HU175537B (enExample)
IE (1) IE44845B1 (enExample)
IL (1) IL50503A (enExample)
IN (1) IN146736B (enExample)
IT (2) IT1070839B (enExample)
LU (1) LU75922A1 (enExample)
MW (1) MW3476A1 (enExample)
MX (1) MX4614E (enExample)
NL (1) NL7609917A (enExample)
NO (1) NO145792C (enExample)
NZ (1) NZ181959A (enExample)
OA (1) OA05445A (enExample)
PH (1) PH13921A (enExample)
PL (1) PL105828B1 (enExample)
PT (1) PT65590B (enExample)
RO (1) RO73511A (enExample)
SE (1) SE431872B (enExample)
YU (1) YU237276A (enExample)
ZA (1) ZA765498B (enExample)
ZM (1) ZM12176A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MW5076A1 (en) * 1975-12-29 1978-02-08 Smith Kline French Lab Pharmacologicalle active compounds
NZ186511A (en) 1977-03-19 1980-11-14 Smith Kline French Lab 3-substituted alkylamino-6-substituted alkyl-1,2,4-triazin-5-ones and pharmaceutical compositions 3-substituted thio-1,2,4-triazin-5-ones
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
NZ186965A (en) 1977-04-20 1980-02-21 Ici Ltd Guanidino derivatives and pharmaceutical compositions
JPS54104816A (en) * 1978-01-27 1979-08-17 Memorex Corp Magnetic recorder tape reel
IN151188B (enExample) * 1978-02-13 1983-03-05 Smith Kline French Lab
PH16240A (en) * 1978-04-11 1983-08-11 Smith Kline French Lab Process for making histamine antagonist
IL57416A (en) * 1978-05-30 1983-03-31 Smith Kline French Lab Nitro compounds,processes for preparing them and compositions containing them
ZA793443B (en) * 1978-07-26 1980-12-31 Glaxo Group Ltd Heterocyclic derivatives
US4374836A (en) 1978-10-16 1983-02-22 Imperial Chemical Industries Ltd. Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
EP0014057B1 (en) 1979-01-18 1985-01-02 Imperial Chemical Industries Plc Guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
JPS55145683A (en) * 1979-04-26 1980-11-13 Smith Kline French Lab Pyrimidone derivative
CA1155842A (en) * 1980-03-29 1983-10-25 Thomas H. Brown Compounds
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
PT75074B (en) * 1981-06-27 1986-02-26 Smith Kline French Lab Process for preparing certain pyrimidone derivatives and compositions containing them
CA1206151A (en) * 1981-12-28 1986-06-17 Richard P. Pioch Pyrimidone anti-ulcer agents
JPS5993074A (ja) * 1982-10-01 1984-05-29 スミス・クライン・アンド・フレンチ・ラボラトリ−ス・リミテツド ピリミドン誘導体
DE8309239U1 (de) * 1983-03-29 1983-09-29 Basf Ag, 6700 Ludwigshafen Bandspule, insbesondere fuer magnetbaender

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them

Also Published As

Publication number Publication date
CS203003B2 (en) 1981-02-27
AT358045B (de) 1980-08-11
IL50503A0 (en) 1976-11-30
IE44845L (en) 1977-04-02
JPS609755B2 (ja) 1985-03-12
GR61307B (en) 1978-10-19
NO763371L (enExample) 1977-04-05
OA05445A (fr) 1981-03-31
IE44845B1 (en) 1982-04-21
FI61701B (fi) 1982-05-31
DE2643670A1 (de) 1977-04-14
HU175537B (hu) 1980-08-28
NZ181959A (en) 1978-07-28
ATA711976A (de) 1980-01-15
CA1067076A (en) 1979-11-27
PL105828B1 (pl) 1979-11-30
NO145792C (no) 1982-06-02
MW3476A1 (en) 1977-11-09
IT7830708A0 (it) 1978-12-11
IL50503A (en) 1980-12-31
AR221682A1 (es) 1981-03-13
SE7610409L (sv) 1977-04-03
DE2643670C2 (de) 1982-07-01
FR2326192B1 (enExample) 1979-01-12
YU237276A (en) 1983-01-21
ZM12176A1 (en) 1977-07-21
MX4614E (es) 1982-07-07
BE846452A (fr) 1977-03-22
DD126563A5 (enExample) 1977-07-27
FI762803A7 (enExample) 1977-04-03
IT1070839B (it) 1985-04-02
CH625801A5 (en) 1981-10-15
PT65590B (en) 1978-03-28
RO73511A (ro) 1981-04-30
FI61701C (fi) 1982-09-10
PT65590A (en) 1976-10-01
SE431872B (sv) 1984-03-05
NL7609917A (nl) 1977-04-05
FR2326192A1 (fr) 1977-04-29
BG25224A3 (bg) 1978-08-10
JPS5246087A (en) 1977-04-12
ZA765498B (en) 1977-08-31
JPS5635674B2 (enExample) 1981-08-19
AU504897B2 (en) 1979-11-01
NO145792B (no) 1982-02-22
LU75922A1 (enExample) 1977-05-06
IN146736B (enExample) 1979-08-25
JPS5695186A (en) 1981-08-01
AU1829576A (en) 1978-04-06
DK442476A (da) 1977-04-03
PH13921A (en) 1980-11-04

Similar Documents

Publication Publication Date Title
SE7610409L (sv) Farmakologiskt aktiva foreningar
ES454656A1 (es) Procedimiento para preparar derivados de 4-pirimidona y 4- tiona.
NO862501D0 (no) Kjemisk forbindelse.
DK0592439T3 (da) Aminosulfonylcarbamater
NO305287B1 (no) AMPA antagonister
DE3575140D1 (de) Dreizyklische oxindole als antientzuendungsmittel.
RU1833371C (ru) Cпocoб пoлучehия amидoпpoизboдhыx 4-фehил-3-буtehoboй kиcлotы
ES450309A1 (es) Procedimiento para preparar compuestos anti-histaminicos.
DK0556308T3 (da) Oxylsulfonylurinstof-ACAT-inhibitorer
ES467953A1 (es) Procedimiento para preparar triazinonas farmacologicamente activas.
ATE50574T1 (de) Aminopyrimidinone als histamin-h2-antagonisten.
DE3264253D1 (de) Pyridine derivatives as histamine h2 antagonists
ATE34978T1 (de) Imidazolinon-derivate als histamin-h2antagonisten.
EP0114750A3 (en) Beta-lactam antibacterial agents
ATE7786T1 (de) Verwendung von wachstumsregulierenden alphaazolylglykolen.
SE8303131D0 (sv) Isoquinoline derivatives
SE8005493L (sv) 4-(haftalenyloxi)piperidin-derivat
DE3066018D1 (en) Guanidine compounds, process for preparing them and compositions containing them
ES456048A1 (es) Procedimiento de preparacion de derivados de la piridoxina.
AU536154B2 (en) Penicillins
SE7901250L (sv) Nytt forfarande for framstellning av tiazolderivat
ES479738A1 (es) Procedimiento para preparar pirimidonas.
KR840003257A (ko) 페남유도체의 제조방법
FR2525606B1 (enExample)
ES485517A1 (es) Un procedimiento para la obtencion de nuevos derivados hete-rociclicos de nitrogeno